D
68.29
0.55 (0.81%)
| Previous Close | 67.74 |
| Open | 67.22 |
| Volume | 4,884,715 |
| Avg. Volume (3M) | 3,907,254 |
| Market Cap | 26,776,987,648 |
| Price / Earnings (TTM) | 48.09 |
| Price / Earnings (Forward) | 33.22 |
| Price / Sales | 6.84 |
| Price / Book | 12.47 |
| 52 Weeks Range | |
| Earnings Date | 23 Apr 2025 - 28 Apr 2025 |
| Profit Margin | 14.29% |
| Operating Margin (TTM) | 16.97% |
| Diluted EPS (TTM) | 1.42 |
| Quarterly Revenue Growth (YOY) | 7.60% |
| Quarterly Earnings Growth (YOY) | -40.80% |
| Total Debt/Equity (MRQ) | 123.36% |
| Current Ratio (MRQ) | 1.47 |
| Operating Cash Flow (TTM) | 989.50 M |
| Levered Free Cash Flow (TTM) | 552.72 M |
| Return on Assets (TTM) | 5.88% |
| Return on Equity (TTM) | 27.63% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Bearish | Mixed |
| Medical Devices (Global) | Bearish | Mixed | |
| Stock | DexCom, Inc. | Bearish | Bearish |
AIStockmoo Score
0.6
| Analyst Consensus | 2.0 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | 0.0 |
| Average | 0.63 |
|
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Mid Growth |
| % Held by Insiders | 0.41% |
| % Held by Institutions | 96.15% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 106.00 (Canaccord Genuity, 55.22%) | Buy |
| Median | 98.50 (44.24%) | |
| Low | 85.00 (Mizuho, 24.47%) | Buy |
| Average | 97.17 (42.29%) | |
| Total | 5 Buy, 1 Hold | |
| Avg. Price @ Call | 60.34 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Barclays | 05 May 2025 | 93.00 (36.18%) | Hold | 0.000 |
| Baird | 02 May 2025 | 105.00 (53.76%) | Buy | 70.78 |
| Canaccord Genuity | 02 May 2025 | 106.00 (55.22%) | Buy | 70.78 |
| Piper Sandler | 02 May 2025 | 90.00 (31.79%) | Buy | 70.78 |
| Mizuho | 10 Apr 2025 | 85.00 (24.47%) | Buy | 67.30 |
| Citigroup | 04 Mar 2025 | 104.00 (52.29%) | Buy | 82.42 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |